ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

0JJM Bioporto A/s

3.20
0.00 (0.00%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Bioporto A/s LSE:0JJM London Ordinary Share DK0011048619 BIOPORTO ORD SHS
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 3.20 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Biological Pds,ex Diagnstics 28.97M -75.92M -0.2268 -14.11 1.07B

Changes in the Board of Directors

16/01/2018 11:22am

GlobeNewswire Inc.


Bioporto A/s (LSE:0JJM)
Historical Stock Chart


From Mar 2019 to Mar 2024

Click Here for more Bioporto A/s Charts.
Changes in the Board of Directors

Today it is announced that BioPorto’s Board of Directors will nominate Britt Meelby Jensen for election as a new Board member at BioPorto’s Annual General Meeting on April 13, 2018.

Britt Meelby Jensen (Danish citizen, born 1973) has extensive global commercial and general management experiences from working in the life sciences area over the past 16 years at Novo Nordisk, Dako and Zealand Pharma. Since 2015 Britt has been the CEO of Zealand Pharma A/S, a medium sized biotech company listed on NASDAQ in Copenhagen and New York. Britt Meelby Jensen holds a Master of Science from Copenhagen Business School and a Master in Business Administration from Solvay Business School in Brussels, Belgium. 

Thomas Magnussen, Chairman of the Board, says: “We are delighted with the opportunity to nominate Britt for election to the Board at the upcoming general meeting. She brings unique international management skills and commercial insights that are complementary to the existing team. We look forward to welcoming Britt on the Board.”   

For further information, please contact:

Thomas Magnussen, Chairman of the Board of Directors Telephone +45 4529 0000, e-mail investor@bioporto.com

About BioPorto

BioPorto Diagnostics A/S is an in-vitro diagnostics company that provides healthcare professionals in clinical and research settings a range of diagnostic tests and antibodies. Our pioneering product portfolio includes assays for underserved disease states such as NGAL for acute kidney injury. BioPorto has its headquarters in Copenhagen, Denmark and is listed on the Nasdaq Copenhagen stock exchange.

http://prlibrary-eu.nasdaq.com/Resource/Download/dd42c247-7537-481d-84b8-6c4ed488a0e9

1 Year Bioporto A/s Chart

1 Year Bioporto A/s Chart

1 Month Bioporto A/s Chart

1 Month Bioporto A/s Chart

Your Recent History

Delayed Upgrade Clock